Tech Unveiled

Your Daily Tech News Blog

NASDAQ

Facebook (FB): Why Is Facebook Stock Still A Buy?

By on December 20, 2020

Facebook (FB): Why Is Facebook Stock Still A Buy?

Facebook stock (NASDAQ: FB) is priced at $276.40 today. What makes it a good and recommended buy is its consistent performance in the last one year or so.

Moreover, what can be attributed to Facebook’s success is its strength and stronghold, especially in the corona pandemic. This happened when more people resorted to online mediums for communication than before.

Facebook Stock’s Success

Furthermore, what can also be attributed to Facebook’s success is the fact that the corona pandemic is going to take much more time to ‘end’ and Facebook is going to be the prime mode of online communication amongst masses, where people stick at home to work.

Its stock, therefore, is going to rise. Facebook is also going to gain because of eCommerce ad growth, which is going to be high in the coming months, especially during Christmas.

Moreover, according to the analysts that cover Facebook stock, 42 have given it a Buy rating, and 6 rate it as hold which is pretty obvious to realize that its status is buy.

The company has a price target of $327.32, which shows a 15% return from its price on Tuesday. Its shares have gained significantly this year (by 41%), as the benchmark S&P 500 index rose by 20%. (More on S&P 500 index).

Furthermore, amongst other reasons to buy Facebook stock is the fact that it has a 52 week period- price target of $316.87 which shows that Facebook stock is going to rise in the coming months.

Facebook Stock Conclusion

Facebook’s stock has been stable and is a must add in your investor basket, especially if you want something concrete in volatile times.

Facebook is leading the ‘big tech groups‘ and has a lot more to gain in the months to come which keeps it in good books.

Stay tuned.

Stock Market Outlook This Friday

By on July 29, 2020

Stock Market Outlook This Friday

Stock Market Outlook This Friday. Things seem awkward as big tech giants are supposed to reveal their earnings this Friday. After the markets close this Thursday, four out of the five FAAMG stocks will report their June quarter results. These include Facebook (at 6:00 pm ET), Amazon (AMZN) at 5:30 pm ET, Apple at 5:00 pm ET and Google/Alphabet at 4:30 pm ET. The one tech giant that will be missing from revealing its earnings this Friday will be Microsoft.

However, since these four names are the ones that are leading the industry, investors and stockholders are hooked to their laptops and phones to realize what is going to go on in the stock market.

The Stock Market

What is interesting is that not only with stock owners benefit from the gains and losses of these four companies. In fact, the truth is that these four make up to 17% of the S&P 500 value and 40% of the Nasdaq 100.

Combined with Microsoft, these five companies hold a huge share of the S&P 500 increase.

Furthermore, because of their outlook and growth rates, it is true that all of these four companies are trading above the S&P 500’s PE multiple of 25x on this year’s earnings and 19.6x on 2021 earnings.

Q2 Earnings: Facebook, Amazon, Apple and Google

What is true is that Q2 earnings of these four companies will be watched carefully by investors and stock holders for the following reasons:

  1. Investors were unsure and markets were volatile in the first quarter of the year due to the corona pandemic.
  2. Since the corona pandemic caused a lot of disturbance and uncertainty in the markets, people were reluctant to invest and gave benefit of doubt to these companies.
  3. People will be hooked to Q2 earnings because it might actually include the full impact of Covid-19 and give directive for Q3 and Q4, which will be more competitive and tough.

Amongst these companies, here is how each performed in 2020:

Facebook Inc. (NASDAQ: FB)

Facebook (NASDAQ: FB) stock gained 13.9% till July 27 against S&P 500 1.4% return.

Wall Street is expecting a Revenue of $16.9 billion as a Q2 2019 result for the company and $17.4 billion for Wall Street’s Q2 2020 Consensus estimate. It also predicts a YOY change of 3%.

Secondly, as far as Facebook earnings are concerned, then Wall Street predicts a Q2 2019 result of $0.91, $1.39 Q2 2020 consensus estimate and 53% YOY change.

Stock Market Outlook This Friday: Tech Unveiled

 Wall Street also expects Facebook’s EPS to jump by 53% by year over year basis.

Facebook has had a tough year but it made a lot of efforts in the last 6 months despite the corona epidemic and security concerns. Thereby, its shares stood in green in the last 6 months. Today, its shares stand at $230.12.

Amazon (AMZN)

Stock Market Outlook This Friday will also include Amazon (AMZN) Inc. revealing its earnings.

Through July 27, Amazon shares were higher by 65.7%. Investors have driven Amazon shares higher on optimism because they were of the opinion that online e-shopping will be at its peak in the corona pandemic and it was. In the first quarter of the year, that was the truth.

Investors are hopeful of more in the 2nd quarter for Facebook.

Furthermore, Amazon’s revenue is expected to be $63.4 billion (its Q2 2019 results), $75-81 billion, its Amazon’s Q2 2020 Guidance, 18%-28% (it’s projected YOY change), $81.1 billion, its Q2 2020 Consensus Estimate and 28% it’s YOY projected change.

Its EPS is expected to be $5.22 in the 2nd quarter of the year.

 Q1, Amazon’s revenue rose by 26% (YOY) to $75.45 billion, topping $75.45 billion.

Amazon’s (NASDAQ: AMZN) shares are valued at $3,000.33.

Alphabet Inc.

Stock Market Outlook This Friday will also include Alphabet Inc. revealing its earnings.

This year, Alphabet’s shares (NASDAQ: GOOGL) are up by 14.5 % (Class A) and 14.4% Class C through July 27. (Google is Alphabet’s parent company).

Wall Street expects a revenue of $38.9 billion in revenue (its Q2 2019 results) and $37.4 billion its Q2 2020 Consensus Estimate, and a 4% Projected Change (YOY).

Its earnings per share were $14.21 (Q2 2019 Result), $8.23 (Q2 2020 Consensus Estimate) and 42% (its Projected Change YOY).

Stock Market Outlook This Friday: Tech Unveiled

To Conclude

According to analysts expectations, Alphabet’s revenue will slightly contract because of a drop in ad sales. Furthermore, because of the world economy shut down in Q2.

In Q1, Alphabet’s revenue increased by 13% (YOY) to $41.2 billion. By March-April, Alphabet too was down but today, its shares stand at $1,503.65.

Stay tuned for more updates at Tech Unveiled.

5 Stocks To Invest In July (2020)

By on July 6, 2020

5 Stocks To Invest In July (2020)

Are you an investor looking to invest? If so then you have stumbled at the right place. At Tech Unveiled, we unveil the best in technology and news, for our readers to make the most out of quick and easy reads. At this time when the market is struggling or have sort of recovered, people want to find out which stocks to invest in. If you are in the same boat, here are 5 stocks to invest in July.

Microsoft

Microsoft is a brand name growth stock that provides income and value. Microsoft, therefore, automatically becomes a top favorite in any investor’s basket. Microsoft (NASDAQ:MSFT). It is one of the 5 stocks to invest in July.

Priced at $209.74, Microsoft has had a consistent performance in the last 6 months, all in green. Despite the corona lockdown, when markets were volatile, Microsoft still did well.

Microsoft has worth in billions today and is a company worth your time and investment.

Zynga

Interestingly, while some may think Zynga is a flus, it isn’t Zynga comes in the long term tech trends. It has an ever-increasing demand and probably one of the safest bets there is.

A part of the interactive entertainment industry, Zynga is an affordable stock (NASDAQ:ZNGA), priced at $9.78. It is relative, mobile and easy to keep in an investor’s basket. Zynga is also one of the 5 stocks to invest in july.

With a consistent growth in the last 6 months and performance in green, Zynga Inc. is worth your time and investment today.

5 Stocks To Invest In July: Tech Unveiled

StoneCo

According to CellPointDigital, StoneCo is a profitable company with shares now a recommended (strong buy). It is trading about 71% times this years expected earnings.

With a share price of $41.06, (NASDAQ:STNE), StoneCo Ltd., though has been in red in the last 6 months, hasn’t been that bad of a performer at the stock exchange.

Most of StoneCo’s growth has been in its domestic market and the results have been impressive.

Procter & Gamble (NYSE:PG)

Procter & Gamble (NYSE:PG) is a consumer product that has had a well-rounded performance in the last many years. Another one of the 5 stocks to invest in July, it is worth your time and investment.

With a nice base of products, Procter & Gamble Co (NYSE:PG), priced at $121.05 is a company worth your investment. Though its stock has been in red in the last 6 months, it is still a stock worth your time and investment.

P&G is not going anywhere in the next few years and therefore, a company worth your investment.

Apple (NASDAQ:AAPL)

Apple Inc. is probably our favorite when it comes to stock investing.

If you are wondering about the list of 5 stocks to invest in July, the final one is Apple (NASDAQ:AAPL).

AAPL, priced at $373.78, never goes out of fashion. Its performance has been noteworthy in the last 6 months, when corona hit the markets.

AAPL had its WWDC event earlier this year which makes it good for the rest of the year. AAPL has had a lot of product releases. With a market cap of 1.62 Trillion, this company is a safe bet and a must keep in your baskets. This because it will always add to your basket’s safety net and make it stronger or be there than altogether not having it or just as a base for your investor basket to watch it grow, as it the safety net.

Stay tuned for more updates at Tech Unveiled.

Stock Pick: Ligand Pharmaceuticals: Why Is Ligand One Of “The’ Investors’ Top Pick These Days”

By on February 8, 2020

Stock Pick: Ligand Pharmaceuticals: Why Is Ligand One Of “The’ Investors’ Top Pick These Days”

The stock market has always been unpredictable and volatile. However, given the fact that 2019 was slow and this is the start of 2020, one must think about what to invest in or what to add in their baskets, especially by the end of the next financial year.

If we understand that stocks and the stock market is tricky, it is difficult to find a pick that can help you diversify and maintain your portfolio both. This is where Ligand Pharmaceuticals comes in.

Ligand Pharmaceuticals: A Mid-Sized Company With A Strong Performance

If we are looking for a Stock Pick that should be in an investor’s basket this year, Ligand Pharmaceuticals (NASDAQ: LGND) is the one to consider.

Recommended by known top investors such as Warren Buffet, Ligand Pharmaceuticals (NASDAQ: LGND) is a mid-sized company, which is well appreciated for its products and offerings. Ligand offers great incredible results through its well-defined and well-equipped company base and products.

If you really want to look at it:

Ligand Pharmaceuticals has a noteworthy demand because of its product services. It will become the new age necessity soon and a well-equipped part of the total pharmaceuticals industry. This is because Ligand produces products that are up-to date with the latest technology and mechanisms. This automatically puts Ligand on the top for investors’.

Stocks To Buy In 2020

Moreover, the company is also an evident part of the pharmaceutical industry and the fact that pharmaceutics are itself a billion dollar industry, Ligand Pharmaceuticals is a company that you might want to think about seriously.

Ligand has had a very solid footing opposed to many other companies. The company has exhibited positive momentum in the last 6 months, to say the least, and is bigger, better and stronger than its competition. It can also help you diversify your portfolios and it is a strong measure of investment on the whole.

Ligand is a solid recommend.  

Profitability: D/E ratio to P/E Ratio

Furthermore, Ligand Pharmaceutical’s D/E ratio as of Dec. 31st, 2019 was 3.578 and off 31st January, 2020 was 3.164.

Overall, in the last many months, Ligand’s D/E ratio was in 3’s which shows that the company is definitely stable and worth investing in.

Ligand Pharmaceuticals By Dividend: Stock Holder Information

Ligand Pharmaceuticals Inc. (NASDAQ: LGND) is a part of the biotechnology industry, which makes it easier for people to apprehend and comprehend. Ligand is opening very strongly on and at the stock market.

Its price stood at $89.51 and it boasts a decent day range and 52-week low high as well; the former value of it is between $89.28 – $91.45, whereas the latter value stands at $84.45-$130.5.

Ligand Pharmaceuticals: Size And Stature

Ligand Pharmaceuticals fall in the ‘advanced pharmaceutical industry’ category. It is a part of the Bio-Tech industry and it is a very well established part of the modern day technology.

Its products are wiser than an average company’s products and with a market cap such as its’, Ligand has a promising future.

Ligand currently employees 101-250 people.

Founded in 1987 as Progenx Inc., Ligand went public in 1992. It has been considered as one of the fastest growing companies till date.

Furthermore, the measure of its performance and stability can be assessed by the fact that it has had a very good and green performance since 2019 to 2020. This is a measure investors must look at before they dive in the future with other unnecessary investments.

Ligand Pharmaceuticals Business Model: Simple And Understandable

Ligand Pharmaceuticals fits in the category of biotechnology, medical and pharmaceuticals. Its products are manufactured using the latest technologies and advanced mechanism.

Some of its most promising products are Kyprolis and Promacta.

Ligand itself has partnered with about 120 companies which includes well known company Captisol. Let us also not forget the fact that these are well-known names in the industry itself.


Ligand Pharmaceuticals Operating History: What’s There To Understand

Ligand Pharmaceuticals is a bio-tech company which focuses on discovery and early development of pharmaceuticals for the critically unmet society of the U.S.

The company also holds Pharmacopeia Inc. together, which shows that it is going to hold its ground, and consistency, in the coming future.

Furthermore, the company has its roots laid down historically. The company has held itself strongly by having a strong product mix and it is essentially there for investors, to remember consistency, quality and design. Ligand has built on its worth since decades.

Moreover…


There is no way to deny the legitimacy of Ligand Pharmaceuticals, as the company has shown promising results since years now and what might be on board for the company is a big IPO as well.

Investors should hold in. Top 10 Stocks To Invest In 2020.

Moreover, this year in 2020, January till May, there will be a lot of involvement in the technology, equipment, manufacturing, research, development and exploring front- an industry directly related to Ligand.

The only thing you would want to consider is that things are moving at a fast pace. Ligand Pharmaceuticals might be your favorite as it is a part of an industry that is a constant. It is ever developing and ever involving.

Furthermore, latest Ligand Pharmaceuticals (LGND) figures reveal that the company opened at $89.42 and closed at $87.81 on 31 January 2020 and was consistent in value till date.

Ligand Pharmaceuticals: Profit Margins

Ligand Pharmaceuticals has had a decent profit margin. As of December 31st, 2019, the company’s Net Profit Margin was 43.16%.

Ligand Pharmaceuticals has had a market cap of 1.572B. With an EPS of 28.29, Ligand Pharmaceuticals is a recommend. It has strong corrective mechanisms; it is consistent and it is worth appreciating, for its caps are in positive and its high and lows are definitely worth noticing. Ligand will always be close to Green.

Ligand Pharmaceuticals Financial Analysis and Conclusion

Ligand Pharmaceuticals return on equity was 7.47% as of September 31, 2019. The company has shown good room and margin to grow and improve because it is a part of one of the biggest industrial sectors in the world today.

Ligand Pharmaceuticals (NASDAQ: LGND) has a 139.37k volume and a $1.6b market cap. With an 84.45 – 130.41 day range, the company is surely in the positives.

Furthermore and finally, if we want to assess Ligand Pharmaceuticals as a stock worth investing in, then it can be said with certainty that the company is designing products that are suitable for the upper level market and a bigger asset for medium sized to small sized companies as well.

This is because its products are designed properly and the company is very well-equipped too.

To Conclude:

Ligand Pharmaceuticals is willing to produce and manufacture, with a promising outlook for 2020.

Trust me, finding momentum in 2020 might become hard if production is low and if overall state of the world is not methodologically correct.

One could benefit immensely from Ligand Pharmaceuticals investment now because health and sickness will always prevail and that is where the demand of companies such as Ligand will come and follow through.

Stay tuned.